CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research Parallel Murine and Human Plaque Proteomics Reveals Pathways of Plaque Rupture Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality Negative Risk Markers for Cardiovascular Events in the Elderly Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Adenosine and adenosine receptor-mediated action in coronary microcirculation CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors: JACC Focus Seminar

Clinical Trial2020 Dec 11;S1936-878X(20)30941-4.

JOURNAL:JACC Cardiovasc Imaging. Article Link

High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonobstructive Coronary Disease: A Randomized Study

J Henzel, C Kępka, M Kruk et al. Keywords: high-risk plaque burden; ASCVD progression; lifestyle intervention; RCT

Full Text PDF